Specifically, the mutation frequencies of CDK6, MET, and NOTCH1 noticeably lower in cases with stage N0 than in those with stage N ≥ 1, whereas LRP1B mutation frequency was remarkably higher in cases without lymph node metastasis. The gene discussed is MET; the disease is metastatic malignant neoplasm in the lymph nodes.